Cloning of the epstein-barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: A loss-of-function mutation of the rhBARF1 immune evasion gene

Journal of Virology

Volumn 85, Issue 3, 2011, Pages 1330-1339

  Ohashi, Makoto ^a   Orlova, Nina ^a   Quink, Carol ^a   Wang, Fred ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL IMMORTALIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE; IMMUNE EVASION; LOSS OF FUNCTION MUTATION; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RHESUS MONKEY; VIRUS GENE; VIRUS IMMUNITY; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; HUMANS; IMMUNE EVASION; LYMPHOCRYPTOVIRUS; MACACA MULATTA; MUTATION; VIRAL PROTEINS; VIRULENCE FACTORS; VIRUS REPLICATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CERCOPITHECINE HERPESVIRUS 15; HUMAN HERPESVIRUS 4; LYMPHOCRYPTOVIRUS; MACACA MULATTA;

EID: 78651407504     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01411-10     Document Type: Article

References (52)

1. Auersperg, N. 1964. Long-term cultivation of hypodiploid human tumor cells. J. Natl. Cancer Inst. 32:135-163.
2. Blake, N. W., et al. 1999. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein- Barr virus nuclear antigen 1. J. Virol. 73:7381-7389.
3. Brockman, W. W., and D. Nathans. 1974. The isolation of simian virus 40 variants with specifically altered genomes. Proc. Natl. Acad. Sci. U. S. A. 71:942-946.
4. Brune, W., M. Messerle, and U. H. Koszinowski. 2000. Forward with BACs: new tools for herpesvirus genomics. Trends Genet. 16:254-259.
5. Calderwood, M. A., A. M. Holthaus, and E. Johannsen. 2008. The Epstein-Barr virus LF2 protein inhibits viral replication. J. Virol. 82:8509-8519.
6. Chang, W. L., and P. A. Barry. 2003. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J. Virol. 77:5073-5083.
7. Chen, A., M. Divisconte, X. Jiang, C. Quink, and F. Wang. 2005. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro. J. Virol. 79:4506-4509. (Pubitemid 40388387)
8. Cohen, J. I., and K. Lekstrom. 1999. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J. Virol. 73:7627-7632.
9. Croft, N. P., et al. 2009. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog. 5:e1000490.
10. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
11. Decaussin, G., F. Sbih-Lammali, M. de Turenne-Tessier, A. Bouguermouh, and T. Ooka. 2000. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res. 60:5584-5588.
12. Delecluse, H. J., T. Hilsendegen, D. Pich, R. Zeidler, and W. Hammerschmidt. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95:8245-8250.
13. de Turenne-Tessier, M., and T. Ooka. 2007. Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide. J. Gen. Virol. 88:2656-2661.
14. Durrbach, A., et al. 2010. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am. J. Transplant. 10:547-557.
15. Fiorini, S., and T. Ooka. 2008. Secretion of Epstein-Barr virus-encoded BARF1 oncoprotein from latently infected B cells. Virol. J. 5:70.
16. + T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue. J. Virol. 79:12681-12691.
17. Franken, M., et al. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
18. Gardella, T., P. Medveczky, T. Sairenji, and C. Mulder. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254.
19. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
20. Grillot-Courvalin, C., S. Goussard, F. Huetz, D. M. Ojcius, and P. Courvalin. 1998. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 16:862-866.
21. Habis, A., G. B. Baskin, M. Murphey-Corb, and L. S. Levy. 1999. Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma. AIDS Res. Hum. Retroviruses 15:1389-1398.
22. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
23. Hitt, M. M., et al. 1989. EBV gene expression in an NPC-related tumour. EMBO J. 8:2639-2651.
24. Hoagland, R. J. 1955. The transmission of infectious mononucleosis. Am. J. Med. Sci. 229:262-272.
25. Horst, D., et al. 2009. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J. Immunol. 182:2313-2324.
26. Houali, K., et al. 2007. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 13:4993-5000.
27. Kanda, T., M. Yajima, N. Ahsan, M. Tanaka, and K. Takada. 2004. Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J. Virol. 78:7004-7015.
28. Marchini, A., H. Liu, and H. Zhu. 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:1870-1878. (Pubitemid 32110177)
29. Mazzara, G. P., A. Destree, and A. Mahr. 1993. Generation and analysis of vaccinia virus recombinants. Methods Enzymol. 217:557-581.
30. Moghaddam, A., et al. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030-2033.
31. Morgan, C., J. W. Pollard, and E. R. Stanley. 1987. Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5. J. Cell. Physiol. 130:420-427.
32. Parker, B. D., A. Bankier, S. Satchwell, B. Barrell, and P. J. Farrell. 1990. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339-346.
33. Peng, R., et al. 2000. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J. Virol. 74:379-389.
34. Raab-Traub, N., T. Dambaugh, and E. Kieff. 1980. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22:257-267.
35. Rangan, S. R., L. N. Martin, B. E. Bozelka, N. Wang, and B. J. Gormus. 1986. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int. J. Cancer 38:425-432.
36. Rao, P., H. Jiang, and F. Wang. 2000. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. J. Clin. Microbiol. 38:3219-3225.
37. Rickinson, A., and E. Kieff. 2001. Epstein-Barr virus, vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
38. Rivailler, P., et al. 2004. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 104:1482-1489.
39. Rivailler, P., Y. G. Cho, and F. Wang. 2002. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol. 76:12055-12068.
40. Rivailler, P., H. Jiang, Y. G. Cho, C. Quink, and F. Wang. 2002. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J. Virol. 76:421-426.
41. Rivailler, P., C. Quink, and F. Wang. 1999. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. J. Virol. 73:8867-8872.
42. Seto, E., et al. 2005. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J. Med. Virol. 76:82-88.
43. Sheng, W., G. Decaussin, S. Sumner, and T. Ooka. 2001. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 20:1176-1185.
44. Smith, G. A., and L. W. Enquist. 2000. A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 97:4873-4878.
45. Strockbine, L. D., et al. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
46. Tarbouriech, N., F. Ruggiero, M. de Turenne-Tessier, T. Ooka, and W. P. Burmeister. 2006. Structure of the Epstein-Barr virus oncogene BARF1. J. Mol. Biol. 359:667-678.
47. Vincenti, F., et al. 2010. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am. J. Transplant. 10:535-546.
48. Wagner, M., Z. Ruzsics, and U. H. Koszinowski. 2002. Herpesvirus genetics has come of age. Trends Microbiol. 10:318-324.
49. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36.
50. Wei, M. X., J. C. Moulin, G. Decaussin, F. Berger, and T. Ooka. 1994. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res. 54:1843-1848.
51. Wei, M. X., and T. Ooka. 1989. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J. 8:2897-2903.
52. Zhang, C. X., G. Decaussin, J. Daillie, and T. Ooka. 1988. Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J. Virol. 62:1862-1869.